Skip to main content
Drug bottle and Pill

Compare Glyburide vs. Afrezza

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Glyburide (Glynase) and Afrezza (insulin human) are both medications used to manage diabetes, but they belong to different medication classes and have distinct characteristics. Glyburide is a sulfonylurea that works by stimulating the pancreas to release insulin, and it is taken orally, usually once or twice a day with meals. Afrezza, on the other hand, is an ultra rapid-acting insulin that is inhaled at the start of meals to help control blood sugar levels. While glyburide is only approved for Type 2 diabetes, Afrezza is approved for both Type 1 and Type 2 diabetes in adults. Glyburide is available in a generic form, whereas Afrezza does not have a lower-cost generic option. Common side effects of glyburide include low blood sugar, nausea, and weight gain, while Afrezza can cause low blood sugar, cough, and throat irritation. Glyburide may interact with other medications that lower blood sugar, and Afrezza is not recommended for people with lung conditions like asthma or chronic obstructive pulmonary disease (COPD).

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.